RBC Capital raised the firm’s price target on Universal Health (UHS) to $206 from $201 and keeps a Sector Perform rating on the shares. The company reported decent results with behavioral volumes improving, albeit remaining below the management’s expectations, the analyst tells investors in a research note. The Tennessee Medicaid directed payment program also helped offset headwinds related to $50M of start-up losses related to its Cedar Hill Medical Center in Washington D.C. and softer behavioral volumes, RBC added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target lowered to $203 from $243 at Baird
- Universal Health Services Faces Revenue Uncertainty Amid Medicaid Dependence and State-Level Risks
- Universal Health’s Strong Financial Performance and Future Growth Potential Justify Buy Rating
- Cantor maintains Neutral rating on Universal Health
- Universal Health price target raised to $259 from $257 at Barclays